L01XY02 pertuzumab and trastuzumab
ATC group of level 5 – chemical substance · in plain English: cancer medicines
This site has the patient leaflet or the SPC of 2 medicines in this group.
- 2 prescription only (POM)
Place in the ATC classification
- L Antineoplastic and immunomodulating agents 1,791 medicines
- L01 Antineoplastic agents 1,025 medicines
- L01X Other antineoplastic agents 225 medicines
- L01XY Combinations of antineoplastic agents 4 medicines
- L01XY02 pertuzumab and trastuzumab 2 medicines
- L01XY Combinations of antineoplastic agents 4 medicines
- L01X Other antineoplastic agents 225 medicines
- L01 Antineoplastic agents 1,025 medicines
Active substances in the group
- Pertuzumab 2 medicines
- Trastuzumab 2 medicines
Medicines
| Medicine | Legal category |
|---|---|
| Phesgo 1200 mg / 600 mg solution for injection SPC | Prescription only (POM) |
| Phesgo 600 mg / 600 mg solution for injection SPC | Prescription only (POM) |
Other groups of the same level
- L01XY01 cytarabine and daunorubicin 2 medicines
Other names of the ATC group
- German: L01XY02 Pertuzumab und Trastuzumab
- Turkish: L01XY02 pertuzumab ve trastuzumab
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group L01XY02
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.